CANF Can-Fite BioPharma Ltd.

$2.33 -2.10%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Can-Fite BioPharma Ltd. (CANF) is a healthcare company in the Pharmaceutical Preparations industry. Shares last traded at $2.33, 83.1% below their 52-week high. Revenue declined 39.9% year over year.

Market Cap

—

Shares Out

—

EPS (TTM)

$-5.97

P/E Ratio

—

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$13.82

52-Week Low

$0.17

Volume

14,089

Avg Vol (3m)

17,083.54

Performance

-30.24%

-32.07%

-26.73%

-55.11%

YTD

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

27.50

SMA (50)

$3.29

SMA (200)

$2.97

Price vs SMA50

-29.10%

Price vs SMA200

-21.52%

ATR (14)

$0.32

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$0M

Net Income

$-10M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

-175.8%

Return on Assets

-103.3%

Current Ratio

3.46

Debt / Equity

—

Revenue Growth (YoY)

-39.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

CANF Dividend History

Per-share growth (1y CAGR)

+134.7%

Fiscal year end	Total dividends paid	Per share*	Payout ratio
2021-12-31	$3M	$0.00	—
2020-12-31	$1M	$0.00	—

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Pharmaceutical Preparations peers

CANF vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.